Eva Mezeiová

Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease

Katarina Chalupova, Jan Korábečný, Manuela Bartolini et al. · European Journal of Medicinal Chemistry · 2019 · 106 citations · Full text

Neuropeptides, Drug Target, Biochemistry +11

The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease

Vendula Hepnarová, Jan Korábečný, Lenka Matoušková et al. · European Journal of Medicinal Chemistry · 2018 · 69 citations · Full text

Medicinal Chemistry, Alzheimer's Disease, Medicine +13

Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation

Katarína Špilovská, Jan Korábečný, Vendula Šepsová et al. · Molecules · 2017 · 46 citations · Full text

7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment

Jan Korábečný, Martin Andrš, Eugenie Nepovimová et al. · Molecules · 2015 · 44 citations · Full text

Neurochemical Biomarkers, 7-Methoxytacrine-p-anisidine Hybrids, Pharmaceutical Chemistry +19

2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease

Eva Mezeiová, Jana Janočková, Rudolf Andrýs et al. · European Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Medicinal Chemistry, Alzheimer's Disease, Medicine +11